GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Pretax Margin %

Biosergen AB (OSTO:BIOSGN) Pretax Margin % : % (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Biosergen AB's Pre-Tax Income for the three months ended in Dec. 2024 was kr-3.75 Mil. Biosergen AB's Revenue for the three months ended in Dec. 2024 was kr0.00 Mil. Therefore, Biosergen AB's pretax margin for the quarter that ended in Dec. 2024 was %.

The historical rank and industry rank for Biosergen AB's Pretax Margin % or its related term are showing as below:


OSTO:BIOSGN's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -121.11
* Ranked among companies with meaningful Pretax Margin % only.

Biosergen AB Pretax Margin % Historical Data

The historical data trend for Biosergen AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB Pretax Margin % Chart

Biosergen AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
- - - - -

Biosergen AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biosergen AB's Pretax Margin %

For the Biotechnology subindustry, Biosergen AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosergen AB's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosergen AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Biosergen AB's Pretax Margin % falls into.


;
;

Biosergen AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Biosergen AB's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-18.791/0
= %

Biosergen AB's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-3.746/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosergen AB  (OSTO:BIOSGN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Biosergen AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Biosergen AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosergen AB Business Description

Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines